Penicillin Allergy Evaluation Access: A National Survey

Christian M Mancini; Xiaoqing Fu; Yuqing Zhang; Kristi Kuper; Lucas T Schulz; Tanaya Bhowmick; Michael Postelnick; Francesca Lee; Rochelle P Walensky; Kimberly G Blumenthal

doi:10.1093/cid/ciaa567

Back

Penicillin Allergy Evaluation Access: A National Survey

Journal article

Peer reviewed

Penicillin Allergy Evaluation Access: A National Survey

Christian M Mancini, Xiaoqing Fu, Yuqing Zhang, Kristi Kuper, Lucas T Schulz, Tanaya Bhowmick, Michael Postelnick, Francesca Lee, Rochelle P Walensky and Kimberly G Blumenthal

Clinical infectious diseases, Vol.71(11), pp.2972-2975

12/31/2020

DOI: https://doi.org/10.1093/cid/ciaa567

PMID: 32421192

Abstract

Anti-Bacterial Agents - adverse effects

Drug Hypersensitivity - diagnosis

Drug Hypersensitivity - epidemiology

Humans

Inpatients

Penicillins - adverse effects

Skin Tests

In a study of 121 hospitals from 38 US states, 44% had access to an allergist for inpatient consultations and 39% had access to inpatient penicillin skin testing, indicating that the majority of US hospitals lack sufficient resources to address inpatient penicillin allergies.

Metrics

16 Record Views

22 Times Cited - Web of Science

See more details

Details

Title: Penicillin Allergy Evaluation Access: A National Survey
Creators: Christian M Mancini - The Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA
Xiaoqing Fu - The Mongan Institute, Massachusetts General Hospital, Boston, Massachusetts, USA
Yuqing Zhang - Harvard Medical School, Boston, Massachusetts, USA
Kristi Kuper - Vizient, Irving, Texas, USA
Lucas T Schulz - Department of Pharmacy, University of Wisconsin Health, Madison, Wisconsin, USA
Tanaya Bhowmick - Division of Allergy, Immunology, and Infectious Diseases, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
Michael Postelnick - Northwestern Memorial Hospital, Department of Pharmacy, Chicago, Illinois, USA
Francesca Lee - Department of Pathology and Internal Medicine, Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA
Rochelle P Walensky - Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
Kimberly G Blumenthal - Harvard Medical School, Boston, Massachusetts, USA
Publication Details: Clinical infectious diseases, Vol.71(11), pp.2972-2975
Date published: 12/31/2020
Grant note: K01 AI125631 / NIAID NIH HHS
Academic Unit: Medicine - Allergy, Immunology, and Infectious Diseases (RWJMS)
Language: English
Resource Type: Journal article
Identifiers: 991031665701804646